344 related articles for article (PubMed ID: 12093891)
1. Multiantigen/multiepitope-directed immune-specific suppression of "complex autoimmune encephalomyelitis" by a novel protein product of a synthetic gene.
Zhong MC; Kerlero de Rosbo N; Ben-Nun A
J Clin Invest; 2002 Jul; 110(1):81-90. PubMed ID: 12093891
[TBL] [Abstract][Full Text] [Related]
2. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.
Mendel Kerlero de Rosbo N; Ben-Nun A
Eur J Immunol; 1996 Oct; 26(10):2470-9. PubMed ID: 8898962
[TBL] [Abstract][Full Text] [Related]
3. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
Mendel I; Kerlero de Rosbo N; Ben-Nun A
Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
[TBL] [Abstract][Full Text] [Related]
4. Treatment of experimental encephalomyelitis with a novel chimeric fusion protein of myelin basic protein and proteolipid protein.
Elliott EA; McFarland HI; Nye SH; Cofiell R; Wilson TM; Wilkins JA; Squinto SP; Matis LA; Mueller JP
J Clin Invest; 1996 Oct; 98(7):1602-12. PubMed ID: 8833909
[TBL] [Abstract][Full Text] [Related]
5. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
[TBL] [Abstract][Full Text] [Related]
6. Encephalitogenic epitopes of myelin basic protein, proteolipid protein, myelin oligodendrocyte glycoprotein for experimental allergic encephalomyelitis induction in Biozzi ABH (H-2Ag7) mice share an amino acid motif.
Amor S; O'Neill JK; Morris MM; Smith RM; Wraith DC; Groome N; Travers PJ; Baker D
J Immunol; 1996 Apr; 156(8):3000-8. PubMed ID: 8609422
[TBL] [Abstract][Full Text] [Related]
7. Antigen-driven tissue-specific suppression following oral tolerance: orally administered myelin basic protein suppresses proteolipid protein-induced experimental autoimmune encephalomyelitis in the SJL mouse.
al-Sabbagh A; Miller A; Santos LM; Weiner HL
Eur J Immunol; 1994 Sep; 24(9):2104-9. PubMed ID: 7522160
[TBL] [Abstract][Full Text] [Related]
8. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
Kerlero de Rosbo N; Mendel I; Ben-Nun A
Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
[TBL] [Abstract][Full Text] [Related]
9. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
Tuohy VK; Yu M; Yin L; Kawczak JA; Kinkel PR
J Autoimmun; 1999 Aug; 13(1):11-20. PubMed ID: 10441163
[TBL] [Abstract][Full Text] [Related]
10. Epitopes of myelin basic protein that trigger TGF-beta release after oral tolerization are distinct from encephalitogenic epitopes and mediate epitope-driven bystander suppression.
Miller A; al-Sabbagh A; Santos LM; Das MP; Weiner HL
J Immunol; 1993 Dec; 151(12):7307-15. PubMed ID: 7505026
[TBL] [Abstract][Full Text] [Related]
11. The myelin-associated oligodendrocytic basic protein (MOBP) as a relevant primary target autoantigen in multiple sclerosis.
Kaushansky N; Eisenstein M; Zilkha-Falb R; Ben-Nun A
Autoimmun Rev; 2010 Feb; 9(4):233-6. PubMed ID: 19683076
[TBL] [Abstract][Full Text] [Related]
12. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
de Rosbo NK; Ben-Nun A
J Autoimmun; 1998 Aug; 11(4):287-99. PubMed ID: 9776706
[TBL] [Abstract][Full Text] [Related]
13. Pathogenic T cells in MOBP-induced murine EAE are predominantly focused to recognition of MOBP21F and MOBP27P epitopic residues.
Kaushansky N; Zilkha-Falb R; Hemo R; Lassman H; Eisenstein M; Sas A; Ben-Nun A
Eur J Immunol; 2007 Nov; 37(11):3281-92. PubMed ID: 17935073
[TBL] [Abstract][Full Text] [Related]
14. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
Klehmet J; Shive C; Guardia-Wolff R; Petersen I; Spack EG; Boehm BO; Weissert R; Forsthuber TG
Clin Immunol; 2004 Apr; 111(1):53-60. PubMed ID: 15093552
[TBL] [Abstract][Full Text] [Related]
15. T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis.
Ota K; Matsui M; Milford EL; Mackin GA; Weiner HL; Hafler DA
Nature; 1990 Jul; 346(6280):183-7. PubMed ID: 1694970
[TBL] [Abstract][Full Text] [Related]
16. Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. II. Fine specificity of effector T cell inhibition.
Tan LJ; Kennedy MK; Miller SD
J Immunol; 1992 May; 148(9):2748-55. PubMed ID: 1374098
[TBL] [Abstract][Full Text] [Related]
17. Predominance of the autoimmune response to myelin oligodendrocyte glycoprotein (MOG) in multiple sclerosis: reactivity to the extracellular domain of MOG is directed against three main regions.
Kerlero de Rosbo N; Hoffman M; Mendel I; Yust I; Kaye J; Bakimer R; Flechter S; Abramsky O; Milo R; Karni A; Ben-Nun A
Eur J Immunol; 1997 Nov; 27(11):3059-69. PubMed ID: 9394837
[TBL] [Abstract][Full Text] [Related]
18. T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis.
Zamvil SS; Mitchell DJ; Moore AC; Kitamura K; Steinman L; Rothbard JB
Nature; 1986 Nov 20-26; 324(6094):258-60. PubMed ID: 2431317
[TBL] [Abstract][Full Text] [Related]
19. Anatomy of T cell autoimmunity to myelin oligodendrocyte glycoprotein (MOG): prime role of MOG44F in selection and control of MOG-reactive T cells in H-2b mice.
Ben-Nun A; Kerlero de Rosbo N; Kaushansky N; Eisenstein M; Cohen L; Kaye JF; Mendel I
Eur J Immunol; 2006 Feb; 36(2):478-93. PubMed ID: 16453383
[TBL] [Abstract][Full Text] [Related]
20. A novel retroviral gene therapy approach to inhibit specific antibody production and suppress experimental autoimmune encephalomyelitis induced by MOG and MBP.
Xu B; Scott DW
Clin Immunol; 2004 Apr; 111(1):47-52. PubMed ID: 15093551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
